Search results

• Methamphetamine
  76 (8): 1169–1174. ISSN 0002-838X.  https://en.wikipedia.org/wiki/Monoamine_releasing_agent#Activity_profiles Kirkpatrick, M. G., Gunderson, E. W., Johanson
  41 KB (5,798 words) - 13:29, 16 April 2024
• 4-FA
  fluorinated analogue of amphetamine. 4-Fluoroamphetamine acts as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine producing
  21 KB (3,439 words) - 15:42, 30 July 2022
• Research chemicals
  drugs such as MAOIs, RIMAs, stimulants and any substance which act as a releasing agent or reuptake inhibitor of neurotransmitters such as serotonin and dopamine
  19 KB (2,209 words) - 23:08, 21 April 2024
• Main Page (section Please don't crawl the wiki. Use our API instead.PsychonautWiki ❤️ Developers. Please report any obstacles.)
  Opioid ⋅ Phenethylamine ⋅ Research chemicals ⋅ Reuptake inhibitor ⋅ Releasing agent ⋅ Substituted amphetamine ⋅ Substituted cathinone ⋅ Substituted pyrrolidine
  20 KB (964 words) - 19:52, 1 May 2024
• 6-APB
  (SERT), respectively. 6-APB also possesses additional activity as a releasing agent of these monoamine neurotransmitters. 6-APB is a potent full agonist
  33 KB (4,870 words) - 14:34, 16 April 2024
• MDMA
  methylated analog of the hemostatic agent hydrastinine. There are no indications of interest in MDMA as an active agent itself. It was not mentioned again
  85 KB (10,499 words) - 14:24, 16 April 2024
• 4-FMA
  structural analog 4-FA, 4-Fluoromethamphetamine is thought to act as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine, producing
  21 KB (3,467 words) - 16:14, 30 July 2022
• 3-MeO-PCP
  MDMA: 3-MeO-PCP acts as a mild serotonin releasing agent and could interact negatively with the serotonin release of MDMA Austria: 3-MeO-PCP is illegal to
  25 KB (3,507 words) - 16:38, 18 January 2024
• Stimulants
  signalling act as reuptake inhibitors (NDRIs, e.g. methylphenidate), releasing agents (NDRAs, e.g. amphetamine) or receptor ligands (e.g yohimbine). Stimulants
  11 KB (1,055 words) - 23:00, 21 April 2024
• Amphetamine
  Additionally, it sees widespread illicit use as a performance enhancing agent and recreational substance. Subjective effects include stimulation, focus
  41 KB (5,607 words) - 19:01, 7 April 2024
• MDA
  primarily as a serotonin-norepinephrine-dopamine reuptake inhibitor and releasing agent.[citation needed] However, MDA is significantly more potent by weight
  31 KB (4,382 words) - 18:51, 7 April 2024
• Nicotine
  widely used substances in the world. It is also used as an antiherbivore agent to deter plant predation and has been used as an insecticide in the past
  22 KB (2,752 words) - 17:28, 7 April 2024
• ΑMT
  psychedelic αMT acts as a relatively balanced reuptake inhibitor and releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine
  25 KB (2,825 words) - 16:14, 28 November 2022
• MDAI
  acts as a putatively non-neurotoxic and highly selective serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. MDAI was
  17 KB (2,560 words) - 07:40, 12 October 2023
• Tramadol
  noradrenaline reuptake. Tramadol acts as an opioid receptor agonist, serotonin releasing agent, norepinephrine reuptake inhibitor, NMDA receptor antagonist, 5-HT2C
  22 KB (3,211 words) - 19:11, 7 April 2024
• 6-APDB
  this furan ring with 5-APDB, 5-MAPDB and 6-MAPDB. 6-APDB acts as a releasing agent and triple reuptake inhibitor of the monoamine neurotransmitters known
  26 KB (4,015 words) - 23:44, 21 April 2024
• Cyclazodone
  function. There is no evidence that releasing agents are directly neurotoxic in humans. However, large doses of releasing agents may cause indirect neurotoxicity
  19 KB (2,675 words) - 16:54, 31 March 2024
• Methylphenidate
  methylphenidate is a dopamine reuptake inhibitor while amphetamine is both a releasing agent and reuptake inhibitor of dopamine and norepinephrine. Each of these
  31 KB (4,250 words) - 20:18, 27 April 2024
• Barbiturates
  explain the superior CNS-depressant effects of these agents to alternative GABA potentiating agents such as benzodiazepines and quinazolinones. At higher
  16 KB (1,815 words) - 09:25, 14 January 2023
• Methylone
  with MDA, MDAI and MDMA. Methylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These neurotransmitters
  19 KB (2,841 words) - 14:21, 16 April 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)